Epikast, a NYC-based medical organization, was founded by Vangelis Vergetis in 2022. The company's core mission is to enhance human-to-human interactions in the healthcare sector by partnering with biopharmaceutical companies to engage key stakeholders such as patients, physicians, and other healthcare providers. Epikast specializes in creating customized and personalized communication experiences across various channels, leveraging behavioral science, data, and the latest technologies to maximize the impact of these interactions.
Notable individuals affiliated with Epikast include its founder, Vangelis Vergetis. The company has quickly made significant strides in the healthcare communication space by forming strategic partnerships with leading biopharmaceutical firms. Epikast's innovative approach has led to improved stakeholder engagement and more effective communication strategies, thereby positively impacting patient outcomes and healthcare provider satisfaction.
